Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
| dc.contributor.author | Mathebula, Lindi | |
| dc.contributor.author | Runeyi, Sinazo | |
| dc.contributor.author | Wiysonge, Charles | |
| dc.contributor.author | Ndwandwe, Duduzile | |
| dc.date.accessioned | 2022-09-13T14:36:54Z | |
| dc.date.available | 2022-09-13T14:36:54Z | |
| dc.date.issued | 2022-06-06 | |
| dc.date.updated | 2022-06-12T03:22:39Z | |
| dc.description.abstract | Since the outbreak of COVID-19, many lives have been impacted especially on the African continent which is already fighting the burden of multiple diseases of poverty. However, clinical research has offered hope for treatment and prevention options for this infectious disease. Despite many COVID-19 clinical trials conducted globally, three countries in Africa account for more than 80% of all trials from the continent registered trials in clinical trial registries. This indicates geographic disparity among COVID-19 research in Africa. From the perspective of clinical trial registration, transparency in clinical research and the availability of data became important for making informed decisions to manage the pandemic. Registries serve as a source of planned, ongoing, and completed trials while allowing efficient funding allocation for research that would not duplicate efforts. Additionally, research gaps can be identified, which provide opportunities for collaboration among researchers. Therefore, a critical lesson learnt during this pandemic is that clinical trial registration is important in facilitating the process of tracking changes made to protocols and minimizing publication bias, thereby promoting and advocating for clinical research transparency. Moreover, registration in a clinical trial registry is a condition for publication and allows for trial summary results to be publicly available. Adhering to the principle of results sharing is especially important for the rapidly growing clinical research activities racing to find evidence-based interventions to end the COVID-19 pandemic. | en_US |
| dc.identifier.apacitation | Mathebula, L., Runeyi, S., Wiysonge, C., & Ndwandwe, D. (2022). Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?. <i>Trials</i>, 23(1), 460. http://hdl.handle.net/11427/36808 | en_ZA |
| dc.identifier.chicagocitation | Mathebula, Lindi, Sinazo Runeyi, Charles Wiysonge, and Duduzile Ndwandwe "Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?." <i>Trials</i> 23, 1. (2022): 460. http://hdl.handle.net/11427/36808 | en_ZA |
| dc.identifier.citation | Mathebula, L., Runeyi, S., Wiysonge, C. & Ndwandwe, D. 2022. Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?. <i>Trials.</i> 23(1):460. http://hdl.handle.net/11427/36808 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Mathebula, Lindi AU - Runeyi, Sinazo AU - Wiysonge, Charles AU - Ndwandwe, Duduzile AB - Since the outbreak of COVID-19, many lives have been impacted especially on the African continent which is already fighting the burden of multiple diseases of poverty. However, clinical research has offered hope for treatment and prevention options for this infectious disease. Despite many COVID-19 clinical trials conducted globally, three countries in Africa account for more than 80% of all trials from the continent registered trials in clinical trial registries. This indicates geographic disparity among COVID-19 research in Africa. From the perspective of clinical trial registration, transparency in clinical research and the availability of data became important for making informed decisions to manage the pandemic. Registries serve as a source of planned, ongoing, and completed trials while allowing efficient funding allocation for research that would not duplicate efforts. Additionally, research gaps can be identified, which provide opportunities for collaboration among researchers. Therefore, a critical lesson learnt during this pandemic is that clinical trial registration is important in facilitating the process of tracking changes made to protocols and minimizing publication bias, thereby promoting and advocating for clinical research transparency. Moreover, registration in a clinical trial registry is a condition for publication and allows for trial summary results to be publicly available. Adhering to the principle of results sharing is especially important for the rapidly growing clinical research activities racing to find evidence-based interventions to end the COVID-19 pandemic. DA - 2022-06-06 DB - OpenUCT DP - University of Cape Town IS - 1 J1 - Trials LK - https://open.uct.ac.za PY - 2022 T1 - Clinical trial registration during COVID-19 and beyond in the African context: what have we learned? TI - Clinical trial registration during COVID-19 and beyond in the African context: what have we learned? UR - http://hdl.handle.net/11427/36808 ER - | en_ZA |
| dc.identifier.uri | https://doi.org/10.1186/s13063-022-06412-8 | |
| dc.identifier.uri | http://hdl.handle.net/11427/36808 | |
| dc.identifier.vancouvercitation | Mathebula L, Runeyi S, Wiysonge C, Ndwandwe D. Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?. Trials. 2022;23(1):460. http://hdl.handle.net/11427/36808. | en_ZA |
| dc.language.iso | en | en_US |
| dc.language.rfc3066 | en | |
| dc.publisher.department | Department of Public Health and Family Medicine | en_US |
| dc.publisher.faculty | Faculty of Health Sciences | en_US |
| dc.rights.holder | The Author(s) | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
| dc.source | Trials | en_US |
| dc.source.journalissue | 1 | en_US |
| dc.source.journalvolume | 23 | en_US |
| dc.source.pagination | 460 | en_US |
| dc.source.uri | https://trialsjournal.biomedcentral.com/ | |
| dc.title | Clinical trial registration during COVID-19 and beyond in the African context: what have we learned? | en_US |
| dc.type | Journal Article | en_US |